U.S. market Closed. Opens in 2 days 2 hours 23 minutes

VYGR | Voyager Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue250.01M40.91M37.41M171.13M104.39M7.62M10.13M14.22M17.33MN/A
Cost of Revenue4.44M6.19M73.79M108.75M119.73MN/AN/AN/AN/AN/A
Gross Profit245.57M34.72M-36.37M62.38M-15.34M7.62MN/AN/AN/AN/A
Operating Expenses123.55M91.74M111.03M143.74M156.07M98.71M82.00M55.52M37.59MN/A
Selling, General & Admin35.82M30.98M37.25M34.99M36.34M33.81M19.74M13.27M9.91M5.47M
Research & Development87.73M60.76M73.79M108.75M119.73M64.91M62.26M42.25M27.68M8.90M
Other Operating Expenses3.00K4.45M2.42M7.70M8.08M2.63MN/AN/AN/AN/A
Operating Income122.01M-50.84M-73.62M27.38M-51.68M-91.09M-71.86M-41.30M-20.25M-14.37M
Other Expenses / Income11.72M4.45M2.42M9.36M8.08M2.63M1.17M1.16M-9.42M-1.95M
Before Tax Income133.74M-46.39M-71.20M36.74M-43.60M-88.47M-70.70M-40.14M-29.67M-16.32M
Income Tax Expenses1.41M16.00K-5.17M-1.66M-2.77M-180.00KN/A52.00KN/AN/A
Net Income132.33M-46.41M-66.03M36.74M-40.83M-88.29M-70.70M-40.19M-29.67M-16.32M
Interest ExpensesN/A1.79M-390.00KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding43.02M38.36M37.67M37.13M35.90M32.07M26.80M25.30M24.93M3.83M
Diluted Shares Outstanding44.57M38.36M37.67M37.35M35.90M32.07M26.80M25.30M24.93M3.83M
EBITDA126.45M-50.84M-73.62M31.20M-51.68M-91.09M-69.10M-39.53M-29.07M-14.18M
EBITDA Margin50.58%-124.27%-196.76%18.23%-49.51%-1,195.63%-681.83%-277.98%-167.72%0.00%
EBIT133.74M-44.60M-71.59M35.08M-43.60M-88.47M-70.70M-40.14M-29.67M-16.32M
EBIT Margin53.49%-109.03%-191.33%20.50%-41.76%-1,161.15%-697.56%-282.29%-171.18%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙